DexCom, Inc. (DXCM)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
93.16-0.75 (-0.80%)
At close: 4:00 PM EDT
People also watch:
PODDNUVAABMDELGXHTWR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open93.59
Prev Close93.91
Bid62.50 x 100
Ask0.00 x
Day's Range92.85 - 93.85
52wk Range47.92 - 96.38
1y Target EstN/A
Market Cap7.81B
P/E Ratio (ttm)-94.87
Beta0.59
Volume433,969
Avg Vol (3m)778,437
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube5 days ago

    ETF’s with exposure to DexCom, Inc. : September 22, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to DexCom, Inc. Here are 5 ETF’s with the largest exposure to DXCM-US. Comparing the performance and risk of DexCom, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Benzinga13 days ago

    BTIG Moves To Neutral On DexCom, But Says Shares Are Not Overvalued

    BTIG cut DexCom, Inc. (NASDAQ: DXCM ) to Neutral from Buy, as the shares have reached its $92 price target. The firm added that the company must focus on profitability "for a sustained run well above ...

  • PR Newswire20 days ago

    Reimbursement of Dexcom CGM Technology for Patients with Type 1 and Type 2 Insulin-Dependent Diabetes is Now Available in Germany

    SAN DIEGO and EDINBURGH, Scotland, Sept. 7, 2016 /PRNewswire/ -- Dexcom, Inc., (DXCM), announced that Germany's Federal Joint Committee (G-BA) will provide reimbursement for Dexcom's Continuous Glucose Monitoring (CGM) Systems for patients with insulin-dependent type 1 and type 2 diabetes. The policy change was approved by Germany's Ministry of Health and has now been initiated. This decision by the G-BA will open the door for many patients to benefit from the advanced CGM technology and help them gain better control of their diabetes.  The new reimbursement policy in Germany only covers technologies that provide alarms and alerts about glucose levels – including the Dexcom CGM System.